$6.00
0.295.08%
At close: Jun 30, 5:00 PM EST
$6.02
0.315.47%
Pre-Market: 8:08 AM EST
Myriad Genetics Inc Earnings Estimates
MYGNNASDAQ
Myriad Genetics Earnings Estimates, EPS & Revenue | NASDAQ:MYGN
Myriad Genetics (MYGN) is scheduled to report Q2 earnings on August 4, 2026. Analysts estimate EPS of $-0.06 and quarterly revenue of $205.88M.
In the most recent quarter (Q1), Myriad Genetics reported EPS of $-0.09, meeting estimates of $-0.09. Revenue came in at $200.40M, missing the estimate of $202.47M by 0.01%.
Over the last 4 quarters, Myriad Genetics has averaged an EPS surprise of 1.20% and a revenue surprise of 0.02%.
Earnings Date
Aug 4
EPS Estimate
$-0.060
Quarterly Revenue Estimate
$205.88M
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$829.00M
Myriad Genetics Earnings History
Analyze the earnings history of Myriad Genetics using advanced sorting and filters.
Loading calendar...
Myriad Genetics (MYGN) Earnings Per Share
The chart below shows Myriad Genetics's reported EPS compared to analyst estimates over recent quarters.
Myriad Genetics (MYGN) Revenue
The chart below shows Myriad Genetics's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is Myriad Genetics (NASDAQ:MYGN) reporting earnings?
Myriad Genetics (MYGN) is scheduled to report earnings on August 4, 2026. The last reported earnings were for reported on May 5, 2026 for Q1.
What were the latest earnings per share (EPS) for Myriad Genetics (NASDAQ:MYGN)?
The Actual EPS was $-0.09, which hit the estimate of $-0.09.
What were Myriad Genetics’s (NASDAQ:MYGN) revenues?
The Actual Revenue was $200.40M, which missed the estimate of $202.47M.
